Latest news for MFA Finl (NYSE:MFApC) Stock

MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company is an internally managed real estate investment trust or REIT.

MFA Financial, Inc. 6.50% Series C Fixed-to-Floating Rate Cumulative Redeemable Preferred Stock

MFA Financial Inc

Telsey Advisory Group analyst Dana Telsey maintains Deckers Outdoor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DECK#NYSE">DECK</a>) with a Outperform, adjusts target to $183 from $183 (forward stock split 6:1).

News

Price Target

Analyst Ratings

DECK

Telsey Advisory Group Maintains Outperform on Deckers Outdoor, Adjusts Price Target To $183 (forward stock split 6:1)

Susquehanna analyst Biju Perincheril maintains ConocoPhillips (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COP#NYSE">COP</a>) with a Positive and lowers the price target from $147 to $144.

Susquehanna Maintains Positive on ConocoPhillips, Lowers Price Target to $144

Cantor Fitzgerald analyst Andres Sheppard initiates coverage on PureCycle Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCT#NASDAQ">PCT</a>) with a Overweight rating and announces Price Target of $14.

Initiation

Cantor Fitzgerald Initiates Coverage On PureCycle Technologies with Overweight Rating, Announces Price Target of $14

<a href="https://www.aljazeera.com/news/liveblog/2024/10/18/live-israel-says-hamas-chief-yahya-sinwar-killed-war-on-gaza-to-continue" title="https://www.aljazeera.com/news/liveblog/2024/10/18/live-israel-says-hamas-chief-yahya-sinwar-killed-war-on-gaza-to-continue">https://www.aljazeera.com/news/liveblog/2024/10/18/live-israel-says-hamas-chief-yahya-sinwar-killed-war-on-gaza-to-continue</a>

Macro Economic Events

Economics

iShares MSCI Israel Capped Investable Market Index Fund

ISRA

Hamas Senior Official Al-Hayya Says Group Is Continuing Path Until Achieving Palestinian People's Ambitions; Says Sinwar's Death Will Turn Into A Curse On 'The Occupiers'; Sinwar's Death Will Only Strengthen The Group; Israeli Hostages Will Not Return Until Aggression On Gaza Stops And Withdrawal Of Israeli Forces

Susquehanna analyst Biju Perincheril maintains APA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APA#NASDAQ">APA</a>) with a Positive and lowers the price target from $52 to $48.

Susquehanna Maintains Positive on APA, Lowers Price Target to $48

WIIM

DRUG

Bright Minds Biosciences shares are trading higher. The company announced a $35 million non-brokered private placement.

<h3>Gainers</h3>
<ul>
<li>Lion Group Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGHL#NASDAQ">LGHL</a>) shares rose 29.8% to $0.27 during Friday's pre-market session. The company's market cap stands at $1.8 million. </li>
<li>Prestige Wealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PWM#NASDAQ">PWM</a>) stock moved upwards by 12.49% to $0.9. The market value of their outstanding shares is at $10.8 million. </li>
<li>UP Fintech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) stock moved upwards by 9.74% to $7.88. The market value of their outstanding shares is at $1.2 billion. </li>
<li>Yiren Digital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YRD#NYSE">YRD</a>) stock increased by 9.54% to $6.08. The company's market cap stands at $528.5 million. </li>
<li>Garden Stage (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSIW#NASDAQ">GSIW</a>) stock rose 7.23% to $1.63. The market value of their outstanding shares is at $25.4 million. </li>
<li>LexinFintech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LX#NASDAQ">LX</a>) shares rose 7.01% to $3.05. The market value of their outstanding shares is at $501.4 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Pineapple Financial (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/PAPL#AMEX">PAPL</a>) shares declined by 8.3% to $0.66 during Friday's pre-market session. The company's market cap stands at $4.8 million. </li>
<li>Netcapital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCPL#NASDAQ">NCPL</a>) shares declined by 5.15% to $1.66. The company's market cap stands at $1.2 million. </li>
<li>Santech Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STEC#NASDAQ">STEC</a>) stock declined by 4.89% to $1.51. The company's market cap stands at $42.3 million. </li>
<li>Western Alliance (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WAL#NYSE">WAL</a>) stock declined by 4.18% to $90.0. The company's market cap stands at $9.9 billion. The company's, Q3 earnings came out yesterday. </li>
<li>New York Community (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NYCB#NYSE">NYCB</a>) stock decreased by 4.12% to $11.87. The market value of their outstanding shares is at $4.9 billion. </li>
<li>MicroSectors FANG Index -3X Inverse Leveraged ETNs due January 8, 2038 (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FNGD#NYSE">FNGD</a>) stock decreased by 3.62% to $19.47. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

FNGD

GSIW

LGHL

NCPL

NYCB

PAPL

STEC

TIGR

12 Financials Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Catheter Precision (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/VTAK#AMEX">VTAK</a>) stock increased by 151.9% to $1.11 during Friday's pre-market session. The company's market cap stands at $3.1 million. </li>
<li>Akanda (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKAN#NASDAQ">AKAN</a>) stock rose 71.13% to $1.66. The company's market cap stands at $4.7 million. </li>
<li>Tenon Medical (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNON#NASDAQ">TNON</a>) shares increased by 39.06% to $4.77. The company's market cap stands at $2.6 million. </li>
<li>cbdMD (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/YCBD#AMEX">YCBD</a>) stock moved upwards by 21.83% to $0.52. The company's market cap stands at $1.9 million. </li>
<li>Tevogen Bio Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TVGN#NASDAQ">TVGN</a>) stock increased by 21.01% to $1.67. The market value of their outstanding shares is at $284.9 million. </li>
<li>Carmell (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTCX#NASDAQ">CTCX</a>) shares increased by 10.77% to $0.53. The market value of their outstanding shares is at $11.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Orgenesis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGS#NASDAQ">ORGS</a>) shares declined by 37.9% to $2.01 during Friday's pre-market session. The market value of their outstanding shares is at $9.5 million. </li>
<li>Molecular Templates (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTEM#NASDAQ">MTEM</a>) shares decreased by 30.11% to $0.65. The company's market cap stands at $4.2 million. </li>
<li>NKGen Biotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NKGN#NASDAQ">NKGN</a>) shares declined by 29.02% to $0.5. The company's market cap stands at $17.5 million. </li>
<li>Chromocell Therapeutics (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/CHRO#AMEX">CHRO</a>) shares fell 12.81% to $0.67. The company's market cap stands at $3.8 million. </li>
<li>Kazia Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KZIA#NASDAQ">KZIA</a>) shares decreased by 12.68% to $0.46. The market value of their outstanding shares is at $13.7 million. </li>
<li>Hepion Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HEPA#NASDAQ">HEPA</a>) shares declined by 11.91% to $0.66. The market value of their outstanding shares is at $3.8 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKAN

CHRO

CTCX

HEPA

KZIA

MTEM

NKGN

ORGS

TNON

TVGN

VTAK

YCBD

12 Health Care Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Jet AI (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JTAI#NASDAQ">JTAI</a>) stock rose 14.9% to $0.11 during Friday's pre-market session. The market value of their outstanding shares is at $3.8 million. </li>
<li>CleanCore Solutions (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/ZONE#AMEX">ZONE</a>) shares rose 13.57% to $1.59. The market value of their outstanding shares is at $12.6 million. </li>
<li>Antelope Ent Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEHL#NASDAQ">AEHL</a>) shares rose 9.3% to $0.63. The market value of their outstanding shares is at $9.2 million. </li>
<li>WANG &amp; LEE Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WLGS#NASDAQ">WLGS</a>) stock increased by 9.16% to $2.62. The company's market cap stands at $39.5 million. </li>
<li>Graphex Gr (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/GRFX#AMEX">GRFX</a>) stock moved upwards by 8.21% to $0.28. The company's market cap stands at $13.7 million. </li>
<li>Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) stock rose 7.74% to $0.85. The company's market cap stands at $16.5 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Safe &amp; Green Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) shares declined by 14.1% to $1.1 during Friday's pre-market session. The company's market cap stands at $2.2 million. </li>
<li>Staffing 360 Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STAF#NASDAQ">STAF</a>) shares fell 13.8% to $2.0. The company's market cap stands at $1.8 million. </li>
<li>ShiftPixy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIXY#NASDAQ">PIXY</a>) stock fell 10.31% to $7.57. The market value of their outstanding shares is at $56.7 million. </li>
<li>Greenwave Tech Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) shares decreased by 8.36% to $0.51. The company's market cap stands at $10.2 million. </li>
<li>SKK Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKK#NASDAQ">SKK</a>) stock fell 6.67% to $3.5. The company's market cap stands at $54.6 million. </li>
<li>Nixxy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NIXX#NASDAQ">NIXX</a>) shares fell 6.3% to $2.53. The company's market cap stands at $10.1 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AEHL

GRFX

GWAV

HTOO

JTAI

NIXX

PIXY

SGBX

STAF

WLGS

ZONE

12 Industrials Stocks Moving In Friday's Pre-Market Session

<h3>Gainers</h3>
<ul>
<li>Sobr Safe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOBR#NASDAQ">SOBR</a>) stock rose 88.7% to $15.0 during Friday's pre-market session. The market value of their outstanding shares is at $4.7 million. </li>
<li>Taoping (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TAOP#NASDAQ">TAOP</a>) stock increased by 17.89% to $0.56. The company's market cap stands at $2.5 million. </li>
<li>OneConnect Financial Tech (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OCFT#NYSE">OCFT</a>) stock rose 14.66% to $2.58. The market value of their outstanding shares is at $100.6 million. </li>
<li>MMTEC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTC#NASDAQ">MTC</a>) stock increased by 13.23% to $0.4. The company's market cap stands at $80.2 million. </li>
<li>HeartCore Enterprises (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTCR#NASDAQ">HTCR</a>) stock moved upwards by 11.07% to $1.1. The company's market cap stands at $22.9 million. </li>
<li>ACM Research (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACMR#NASDAQ">ACMR</a>) stock increased by 8.81% to $20.68. The company's market cap stands at $1.2 billion. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cemtrex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) shares decreased by 15.7% to $0.35 during Friday's pre-market session. </li>
<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) stock declined by 7.11% to $0.65. The market value of their outstanding shares is at $3.6 million. </li>
<li>Phunware (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PHUN#NASDAQ">PHUN</a>) shares fell 6.15% to $7.02. The company's market cap stands at $79.6 million. </li>
<li>Zapata Computing Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZPTA#NASDAQ">ZPTA</a>) shares declined by 5.66% to $0.1. The company's market cap stands at $3.8 million. </li>
<li>Zeta Global Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) shares declined by 5.04% to $28.49. The market value of their outstanding shares is at $6.5 billion. </li>
<li>Signing Day Sports (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGN#AMEX">SGN</a>) stock declined by 4.85% to $0.23. The company's market cap stands at $4.2 million. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ACMR

AUUD

CETX

HTCR

OCFT

PHUN

SOBR

TAOP

ZETA

ZPTA

12 Information Technology Stocks Moving In Friday's Pre-Market Session

Susquehanna analyst James Friedman maintains Fiserv (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FI#NYSE">FI</a>) with a Positive and raises the price target from $190 to $230.

Susquehanna Maintains Positive on Fiserv, Raises Price Target to $230

B. Riley Securities analyst Dave Kang downgrades Coherent (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COHR#NYSE">COHR</a>) from Buy to Neutral and maintains the price target from $86 to $86.

Downgrades

COHR

B. Riley Securities Downgrades Coherent to Neutral, Maintains Price Target to $86

Republic Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RBCAA#NASDAQ">RBCAA</a>) reported quarterly earnings of $1.37 per share which beat the analyst consensus estimate of $1.21 by 13.22 percent. This is a 24.55 percent increase over earnings of $1.10 per share from the same period last year.

Earnings

RBCAA

Republic Bancorp Q3 EPS $1.37 Beats $1.21 Estimate

Cantor Fitzgerald analyst Sarah James maintains Elevance Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELV#NYSE">ELV</a>) with a Overweight and lowers the price target from $600 to $485.

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

Cantor Fitzgerald Maintains Overweight on Elevance Health, Lowers Price Target to $485

The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Ecopetrol SA (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EC#NYSE">EC</a>)</h3>
<ul>
<li>On Oct. 16, Ecopetrol announced the pricing of cash tender offer for any and all of its outstanding 5.375% notes due 2026. The company's stock fell around 11% over the past five days and has a <a href="https://www.benzinga.com/quote/EC">52-week low of $8.13</a>.</li>
<li>RSI Value: 26.20</li>
<li>EC Price Action: Shares of Ecopetrol fell 1.1% to close at $8.15 on Thursday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101824&amp;t=be2bearmibe3na1"> latest EC news.</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="897" height="836" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18075906/image-159.png" alt="" class="wp-image-602466" style="width:753px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18075906/image-159.png 897w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18075906/image-159-300x280.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18075906/image-159-768x716.png 768w" sizes="(max-width: 897px) 100vw, 897px" /></a></figure>
<h3 class="wp-block-heading">Torm PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRMD#NASDAQ">TRMD</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On July 23, Evercore ISI Group analyst Jonathan Chappell maintained TORM with an Outperform and raised the price target from $45 to $48. The company's stock fell around 17% over the past month. It <a href="https://www.benzinga.com/quote/TRMD">has a 52-week low</a> of $26.10.</li>
<li>RSI Value: 27.08</li>
<li>TRMD Price Action: Shares of Torm fell 0.7% to close at $29.90 on Thursday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101824&amp;t=be2bearmibe3na1">trend in TRMD stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/pro/?utm_source=BZprocontent101824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="926" height="841" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18080117/image-160.png" alt="" class="wp-image-602470" style="width:701px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18080117/image-160.png 926w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18080117/image-160-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/10/18080117/image-160-768x698.png 768w" sizes="(max-width: 926px) 100vw, 926px" /></a></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/10/41379749/abbvie-is-doing-very-well-but-jim-cramers-favorite-abbott-laboratories">AbbVie Is Doing &#8216;Very Well&#8217; But Jim Cramer&#8217;s Favorite? Abbott Laboratories</a></li>
</ul>

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

TRMD

Top 2 Energy Stocks Which Could Blast Off This Month

Replaces Previous Program And Includes Potential 10b5-1 Plan For Repurchases

Buybacks

BSRR

Sierra Bancorp Approves New Share Repurchase Program For Up To 1M Shares, Effective November 1, 2024, Through October 31, 2025

Morgan Stanley analyst Kristine Liwag maintains FTAI Aviation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTAI#NASDAQ">FTAI</a>) with a Overweight and raises the price target from $140 to $148.

FTAI

Morgan Stanley Maintains Overweight on FTAI Aviation, Raises Price Target to $148

<a href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4281406-1&amp;h=1093660941&amp;u=https%3A%2F%2Fwww.vioc.com%2F&amp;a=Valvoline+Inc.">Valvoline Inc.</a>&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VVV#NYSE">VVV</a>), the quick, easy, trusted leader in preventive automotive maintenance announces the planned retirement of its Chief Financial Officer Mary Meixelsperger. Meixelsperger will continue as CFO until a successor is hired and will remain with the Company through the subsequent transition period. The Company has initiated a comprehensive search with the assistance of a leading executive search firm to identify a successor for this position, which will include both internal and external candidates.

Management

Valvoline's CFO Mary Meixelsperger Announces Planned Retirement; Meixelsperger Will Continue As CFO Until A Successor Is Hired And Will Remain With The Company Through The Subsequent Transition Period

And Pre-Funded Warrants At $21.70 Per Share; PFWs Exercisable At $0.001 Per Share For Up To 5 Years

Bright Minds Biosciences Announces $35M Private Placement Of Common Shares

-- Phase 3 abstract selected for presentation in "Best Abstract" session --
<a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.vrtx.com&amp;esheet=54137554&amp;newsitemid=20241017447532&amp;lan=en-US&amp;anchor=Vertex+Pharmaceuticals+Incorporated&amp;index=1&amp;md5=6c6ece64284e740aec404ef03c805cb0">Vertex Pharmaceuticals Incorporated</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRTX#NASDAQ">VRTX</a>) today announced that the company will present its pivotal Phase 3 data on suzetrigine, an investigational, oral, highly selective NaV1.8 pain signal inhibitor for the treatment of moderate-to-severe acute pain, at the annual meeting of the American Society of Anesthesiologists (ASA), taking place from October 18-22, 2024 in Philadelphia, Pennsylvania.
<ul>
<li>Abstract A1187 — "Randomized, Placebo-Controlled, Phase 3 Trials of Suzetrigine, a Non-Opioid, Pain Signal Inhibitor for Treatment of Acute Pain After Abdominoplasty or Bunionectomy" will be presented as an oral presentation on Sunday, October 20, during the "Best Abstract" session, which runs from 8:00-11:00 a.m. ET, as well as the Education session which runs on Monday, October 21, from 1:30-2:30 p.m. ET.</li>
<li>Abstract A2074 — "A Phase 3, Single-Arm Study of Suzetrigine, a Non-Opioid, Pain Signal Inhibitor For Treatment of Acute Pain From Surgical and Non-surgical Conditions" will be presented in a poster session on Saturday, October 19, from 10:00-11:30 a.m. ET.</li>
</ul>
This will be the first time the suzetrigine Phase 3 data will be presented to the medical community following the <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fnews.vrtx.com%2Fnews-releases%2Fnews-release-details%2Fvertex-announces-positive-results-vx-548-phase-3-program&amp;esheet=54137554&amp;newsitemid=20241017447532&amp;lan=en-US&amp;anchor=January+2024&amp;index=2&amp;md5=4170e8d07ce4d104c426500079dbc880">January 2024</a> announcement that the Phase 3 trials were positive. The Phase 3 program included two randomized, double-blind, placebo-controlled trials, one following abdominoplasty surgery and one following bunionectomy surgery, as well as a single arm safety and effectiveness study which enrolled patients with a broad range of surgical and non-surgical pain conditions. Results from all three studies demonstrate compelling and consistent efficacy and safety across multiple acute pain conditions and settings.

Biotech

General

VRTX

Vertex To Present Phase 3 Data Highlighting Suzetrigine's Potential As A First-In-Class, Highly Selective Pain Signal Inhibitor At The American Society Of Anesthesiologists Annual Meeting

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Top Stock Ideas Sent Daily — Join and Gain Your Edge

Comments

MFA Finl

News

Latest news for MFA Finl (NYSE:MFApC) Stock